Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,995 | 23,054 | 10,495 | 7,706 | 11,586 |
| Marketable Securities | 129,669 | 74,156 | 6,499 | 33,774 | 23,209 |
| Receivables | 304 | 5,000 | N/A | N/A | 347 |
| Other current assets | 0 | 126 | 165 | 186 | 96 |
| TOTAL | $181,562 | $103,544 | $18,528 | $42,274 | $37,229 |
| Non-Current Assets | |||||
| PPE Net | 2,905 | 69 | 77 | 64 | 86 |
| Other Non-Current Assets | 2,280 | 634 | 754 | 741 | 159 |
| TOTAL | $5,185 | $703 | $831 | $805 | $245 |
| Total Assets | $186,747 | $104,247 | $19,359 | $43,079 | $37,474 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,108 | 2,700 | 509 | 1,355 |
| Accounts payable and accrued liabilities | 1,973 | 1,354 | 965 | 1,081 | 2,120 |
| Accrued Expenses | 8,588 | 2,828 | 4,501 | 3,336 | 3,388 |
| Other current liabilities | N/A | 6,091 | 1,145 | 1,220 | 13,596 |
| TOTAL | $14,415 | $16,310 | $9,311 | $6,146 | $20,459 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,990 | 6,098 | 8,799 | 3,152 |
| Other Non-Current Liabilities | 1,914 | 0 | 13 | 19 | 13 |
| TOTAL | $1,914 | $2,990 | $6,111 | $8,818 | $3,165 |
| Total Liabilities | $16,329 | $19,300 | $15,422 | $14,964 | $23,624 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,470 | 58,502 | 28,752 | 23,447 | 15,240 |
| Common Shares | 6 | 4 | 2 | 2 | 1 |
| Retained earnings | -523,064 | -450,516 | -422,959 | -396,288 | -380,759 |
| Other shareholders' equity | -58 | -44 | -1 | -21 | -14 |
| TOTAL | $170,418 | $84,947 | $3,937 | $28,115 | $13,850 |
| Total Liabilities And Equity | $186,747 | $104,247 | $19,359 | $43,079 | $37,474 |